FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
Glenvastatin, 122254-45-9, Glenvastatin Intermediate 122287-13-2, stock 827.5g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
Glenvastatin, 122254-45-9, Glenvastatin Intermediate 86030-96-8, stock 914.9g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
Glenvastatin, 122254-45-9, Glenvastatin Intermediate 123930-22-3, stock 643.2g, white powder, assay by HPLC 99.8%, HNMR, LCMS we supply. |
Glenvastatin, 122254-45-9, Glenvastatin Intermediate /, stock 502.9g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply. |
Glenvastatin, 122254-45-9, Glenvastatin Intermediate 122254-10-8, stock 236g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
Glenvastatin, 122254-45-9, Glenvastatin Intermediate 122254-45-9, stock 514g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply. |